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Abstract
Purpose: The primary purpose of this dissertation was to examine the relationship
between age and receipt of three components of pre-end stage renal disease care prior to
first initiation o f hemodialysis, and to explore the implications of differences in
interpretation of funding policies for dialysis services in Puerto Rico and the U.S.
mainland.
Background: The growing burden of chronic kidney disease (CKD) is a national public
health concern, particularly within the aged population. It is estimated that more than 25
million Americans are living with some level of kidney disease, with an increasing
prevalence noted with increasing age (Coresh et al., 2007). Although the Center for
Medicare and Medicaid Services (CMS) is the primary payer for CKD and ESRD
services, differences in reimbursement policy interpretation between the U.S. mainland
and Puerto Rico result in additional burdens for those served. Pre-end stage renal disease
(ESRD) clinical care can improve outcomes for maintenance hemodialysis patients
particularly within the elder population.
Methods: Data on the extent of pre-ESRD care by age were derived from the U.S. Renal
Disease Data System for all patients started on dialysis from 2005 to 2010. Study
variables included: (a) receipt of nephrology care 12 months prior to starting dialysis, (b)
receipt of dietitian care at any time prior to starting dialysis, and (c) use of AVF at first
dialysis. Data for the policy analysis was derived from CMS documents and interviews
with stakeholders and regulatory agencies.

Results: Less than 2% of MHD patients received all three pre-ESRD care elements, and
63.3% received none of the three elements o f care. The mean number of pre-ESRD care
elements received by the oldest group (>80 years) did not differ from the youngest group
(<55 years), but was less than the 55-66 and 67-79 years groups. The policy analysis
revealed regional variations in the interpretation of the coordination of ESRD benefits
between the Territory o f Puerto Rico and the national health system.
Implications: Major efforts are needed to ensure comprehensive pre-ESRD care for all
patients with chronic kidney disease as well as a harmonizing of ESRD coordination of
benefits for dialysis patients.
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Chapter 1
Dissertation Introduction
The growing burden o f chronic kidney disease (CKD) is a national public health
concern, particularly within the aged population. It is estimated that more than 25 million
Americans are living with some level of kidney disease, with an increasing prevalence
noted with increasing age (Coresh et al., 2007). Two key factors contributing to the
increasing national prevalence of CKD are an aging population and the increasing
prevalence of the leading CKD risk factors, diabetes and hypertension (Erdem, Prada, &
Haffer, 2013). People aged >65 years comprise the fastest growing segment of the kidney
failure population (Drawz, Babineau, & Rahman, 2012; United States Renal Data System
[USRDS], 2013a). Both diabetes- and hypertension-related kidney diseases are more
common with increasing age (Yan et al., 2013). Diabetes now accounts for an estimated
45% of new cases of kidney failure and hypertension for an additional 30% (USRDS,
2013b). The implication o f increased numbers o f older persons and increased rates of
CKD risk factors is a greater number of persons developing end-stage renal disease
(ESRD), thereby creating a substantial burden for the national health care system. Renal
replacement therapy with dialysis or kidney transplantation is a life-saving intervention,
but is costly (USRDS, 2013c). Also, ESRD patients treated with renal replacement
1
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are at high risk for hospitalization or death, which is dependent in part on the quality of
pre-ESRD care. Understanding the quality of pre-ESRD care for the elderly is a Centers
for Medicaid and Medicare Services (CMS) priority (St. Peter, Khan, Ebben, Pereira, &
Collins, 2004).
Early detection and effective treatment are critical to slowing CKD progression to
ESRD. Many studies have found early nephrology care to be associated with slowed
progression o f ESRD and improved quality outcomes (Echouffo-Techeugui & Kengne;
2012; Fayer, Nascimento, & Abdulkader, 2011). Once renal replacement therapy is
imminent, receipt of three elements of care related to quality indicators established by the
Centers for Medicare and Medicaid Services (CMS) results in reduced morbidity and
mortality and improved quality outcomes for patients starting dialysis. These elements of
pre-ESRD care include management of nephrology and dietary kidney care, as well as
early placement of an arteriovenous fistula (AVF).

Purpose Statement and Hypothesis
This dissertation occurred in three parts: two studies and a related policy analysis.
The purposes o f the two studies were to examine age-related differences in the receipt of
the following quality patient care indicators at the initiation o f incident hemodialysis: (a)
early nephrology management; (b) dietary consultation, and (c) the placement of an
ateriovenous fistula (AVF). The first study was used as a pilot study in which the
investigator learned to mine data contained in the U. S. Renal Data System (USRDS) and
was focused on the relationship between age and placement of an AVF, prior to initiation
of dialysis. The second study examined the relationships between age and other selected
patient characteristics and receipt of all three quality care indicators.
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The author hypothesized that persons aged >67 years receive a lower level of quality
of care than younger persons based on receipt of the quality patient care indicators
identified. To control for Medicare insurance eligibility at age 65 years the author chose
age 67 (so a person could get signed up and have Medicare related access to care for at
least a year) and then engaged in further stratification of ESRD patients into those less
than 55 years of age, 55-66 years, 67-69 years, and over 80 years.
The purpose of the policy analysis was to gain a clearer understanding of the
implications of differences in the interpretation and implementation of the Coordination
Period policy in Puerto Rico for individual patients and health care delivery systems.
Research Questions
The first study addressed the first of the research questions posed below. The second
study addressed questions one through three, and the policy analysis addressed question
four.
1. Is there a difference in rate of placement of an AVF prior to initiation of
hemodialysis between persons aged >_67 years and those <67 years?
2. Is there a difference in the rate of receipt of early nephrology care prior to
initiation o f hemodialysis between persons aged > 6 7 years and those <67 years?
3. Is there a difference in the rate of receipt of dietary care prior to initiation
hemodialysis between persons aged > 6 7 years and those <67 years?
4. Is there a difference in the interpretation and implementation o f the Coordination
Period policy in Puerto Rico?
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Methods
The first two studies were retrospective correlational comparative descriptive studies.
According to Polit and Beck (2012, p 224), “ retrospective studies are best utilized when
applied when a phenomenon existing in the present is linked to the phenomena that
occurred in the past.” Such designs specifically address phenomena in which the
dependent variables’ (quality care indicators) relationship to the independent variable
(age) has already occurred. For this study, all data were retrospective. The United States
Renal Disease System (USRDS) was used to extract pre-collected data over a five-year
period, 2005 through 2010. The studies examined aged-related differences in the receipt
of the following three elements of pre-ESRD care: (a) receipt of care by a nephrologist at
least 12 months prior to starting dialysis, (b) receipt o f care by a dietician at any time
prior to starting dialysis, and (c) whether a patient used an AFV at the first outpatient
dialysis session.
The policy analysis was conducted over an 8-month period. We conducted a search of
Centers for Medicaid & Medicare Services (CMS) regulatory documents and interviewed
stakeholders including healthcare professionals, patients, Puerto Rico healthcare
agencies, and CMS personnel from the New York regional office. Greater details on the
study methods are provided in the manuscripts included in Chapters 2 ,3 , and 4
respectively.

Integration of the Three Papers
The dissertation results were reported in three manuscripts. The first manuscript,
Relationship between Age and Timely Placement o f Vascular Access in Incident Patients
on Hemodialysis, examined the use of an arteriovenous fistula (AVF) at the first
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outpatient hemodialysis treatment among U.S. incident patients on hemodialysis. The
second manuscript, entitled Relationship between Age and Pre-End Stage Renal Disease
Care in Hemodialysis Patients addressed age-related variations in the receipt of the
composite of recommended care, including nephrologist and dietician care and use of
AVF at first outpatient hemodialysis; and the third manuscript, Regional Variations in the
Interpretation o f the ESRD 30-Month Coordination Period, reviewed the 30-month
ESRD Coordination Period policy in the Territory of Puerto Rico over an 8-month
period. The policy analysis revealed regional variations in the interpretation o f the
coordination of ESRD benefits between the Territory of Puerto Rico and the U.S.
regulatory guidelines. The three manuscripts together indicate that major efforts are
needed to ensure comprehensive pre-ESRD care for patients o f all ages with chronic
kidney disease as well as a harmonizing of ESRD coordination of benefits for dialysis
patients. The three manuscripts are included in Chapters 2, 3, and 4, respectively.

Summary
The role of the nephrology nurse in the continuum of care for both the CKD and
ESRD patient provides a number of expanded opportunities to assist in policy
development and improved quality of care for this population. The research findings and
policy analysis may help to fill gaps in the literature on age-related factors associated
with quality care indicators for patients with ESRD and define future areas of research
that would improve the care for all patients requiring advanced chronic disease care. In
addition, the studies highlight the need for further exploration o f specific interventions at
provider and patient/family levels that may increase access to timely quality care for

patients with advanced CKD and the development of a nurse practitioner specialty such
as a nephrology nurse practitioner. The confluence of these findings can lead to national
dialysis policy revision or development of new policies to better meet the needs o f this
patient population.
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Abstract
Background and purpose: Placement of an arteriovenous fistula (AVF) prior to
initiating dialysis can affect clinical outcomes for patients who subsequently initiate
chronic hemodialysis treatments. Age-related variation in receipt o f a functioning AVF
prior to initiating dialysis is not well known. The purpose of this study was to examine
age-related rates in use o f AVF at the first outpatient dialysis treatment among U.S.
incident patients on hemodialysis.
Findings: Among 526,145 identified, the use of AVF at the first outpatient dialysis
treatment was lower in the youngest (<55 year) and oldest (>80 year) vs. both 55-66 year
and 67-79 year age groups. These findings persisted after adjusting for demographics,
lifestyle behavior, employment and insurance status, physical/functional conditions, and
comorbid conditions.
Conclusions: The presence of a functioning AVF at initial dialysis treatment varies by
age. Modifying healthcare policy and/or expanding the role of the renal nurse practitioner
should be considered to address this issue.
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Introduction
Chronic kidney disease (CKD) is a significant public health problem affecting
over 20 million people in the United States (Centers for Disease Control and Prevention
[CDC], 2012; Rettig, Norris, & Nissenson, 2008). Based on the global contribution of
CKD to premature mortality and morbidity, the World Health Organization (WHO)
added CKD to its action plan for the prevention and control o f noncommunicable
diseases (WHO, 2010). Early detection and early nephrology care influence a multitude
of public health consequences associated with psychosocial burdens and cost for patients
with advanced CKD. Access to quality care for patients with advancing CKD may vary
by race/ethnicity and geographic location (Yan, Cheung, et al., 2013). As such,
arteriovenous fistula (AVF) placement prior to dialysis is an important indicator of preESRD care and a Centers o f Medicare and Medicaid (CMS) clinical performance
measure (CPM) (Arbor Research Collaborative for Health & University of Michigan
Kidney Epidemiology and Cost Center, 2013). Other performance measures monitored
by CMS include the early management and surveillance of: (a) anemia, (b) mineral and
bone disease, (c) infection control, and (d) kidney transplant list and waiting time, all of
which contribute to the overall quality of care for patients with progressive CKD
approaching the need for renal replacement therapy (RRT) (CMS, 2007).
The American Nephrology Nurses' Association (ANNA, 2013) has taken the
position that all patients requiring maintenance hemodialysis therapy should have a
functioning permanent vascular access in place before initiating hemodialysis and that
access placement be established in stage 4 of CKD. AVF is strongly associated with
lower rates o f infection and mortality (Wish; 2010). One of every two patients starting
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hemodialysis is over 65 years of age (United States Renal Data System [USRDS] 2013)
and many factors that influence AVF success such as comorbidities, smaller vessel size,
and atherosclerotic disease are more prevalent in older patients and could influence the
successful and timely placement of an AVF.
Two key factors contributing to the increasing prevalence of CKD are an aging
population and the increasing prevalence of the leading CKD risk factors, diabetes and
hypertension (Erdem, Prada, & Haffer, 2013). People over 65 years of age comprise the
fastest growing segment of the kidney failure population (Drawz, Babineau, & Rahman,
2012; USRDS, 2013). Both diabetes and hypertension are more common with increasing
age (Yan, Norris, et al., 2013). Diabetes now accounts for an estimated 45% of new cases
of kidney failure and hypertension for an additional 30% (USRDS, 2013). The
implications o f aging and ESRD for the national healthcare system are substantial and
understanding the quality of pre-ESRD care for the elderly is a CMS priority.
This study was conducted to assess potential age-related differences in AVF
placement. We hypothesized that older patients were less likely to have a functioning
AVF in place at the first dialysis treatment. To test this, we performed a national
population analysis to assess age-related differences in the use o f AVF at the first dialysis
treatment.

Methods
Data Sources and Study Population
The study included all new maintenance dialysis patients treated with renal
replacement therapy living in any of the 50 states or the District o f Columbia who were
18 years of age or older at the time of initiation o f dialysis and entered in the United

States Renal Data System (USRDS) between 2005 and 2010. USRDS is a national
population-based registry that includes almost all U.S. patients with kidney failure. In
2005, the CMS ESRD Medical Evidence (ME) Report was revised to include information
on pre-renal failure care received during the year prior to initiation of renal replacement
therapy, so data collection included all patients who completed the revised ME form.
Study Variables
Data extracted from the USRDS included whether a patient used an AVF at the
first outpatient hemodialysis session. Additional data was extracted to assess whether or
not patients had received care by a nephrologist at least 12 months prior to starting
dialysis, and whether or not patients had received care by a dietitian at any time prior to
starting dialysis. Data on patient variables such as demographic characteristics,
employment status, health insurance coverage, and comorbid conditions were also
obtained from the USRDS. Data included gender, race and ethnicity, age at dialysis
onset, lifestyle behavior (current smoking), health care access, health insurance status at
the initiation of dialysis, physical/functional conditions, and various comorbid conditions
(e.g., diabetes, hypertension, cardiovascular diseases, and cancer). Employment status at
six months prior to ESRD was used as a proxy measure of access to health care. Each
patient’s health insurance status was assigned to one of four categories: no insurance,
Medicaid only, Medicare only, and other including employer-group only and/or two or
more carriers. The study was approved by the Institutional Review Board (IRB) for
Health Sciences Research at University of Virginia.

Statistical Analysis
We assessed the differences in use of an AVF at the first outpatient dialysis
session by comparing percentages of patients on hemodialysis with AVF across four age
categories (<55 years, 55-66 years, 67-79 years, >80 years of age). We examined the
unadjusted odds ratios with logistic regression and then the odds ratios adjusted for
patient characteristics, including demographics, lifestyle behavior, employment status
and insurance, physical/functional conditions, and various comorbid conditions as listed
in Table 1. The purpose o f adjusted analysis was to assess whether the age related
differences in use o f an AVF at the first outpatient dialysis session persisted after
accounting for the patient factors considered. To compare these four age groups, we
present results o f six pairwise comparisons by the order of age group: age groups of 5566 years, 67-79 years, and > 80 years compared with the youngest age group (<55 years).
Then age groups of 67-79 years and > 80 years compared with the second youngest age
group (55-66 years), and finally the age group of > 80 years compared with the third
youngest group (67-79 years).
Results
Patient Characteristics
Patient characteristics are presented in Table 1. O f the 559,056 patients reviewed,
153,611 (27.5%) were <55 years of age, 154,126 (27.6%) were 55-66 years of age,
168,044 (30.0%) were 67-79 years of age, and 83,275 (14.9%) were >80 years of age.
Compared to older patients, those <55 years o f age were more likely to be male, of a
racial/ethnic minority, uninsured, less likely to be employed at 6 months before ESRD,
and less likely to have most comorbid medical conditions.
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Regression Analyses
Our logistic regression for AVF was restricted to the subset of incident patients on
hemodialysis at the ESRD onset (N= 526,145). Unadjusted logistic regression analyses
were first performed comparing the likelihood of using an AVF at first dialysis (Table 2)
among the four age groups. Six pair-wise comparisons were made: 55-66 years, 67-79
years, and >80 years against the reference group (<55 years); 67-79 years, and >80 years
compared to the 55-66 year-old group; and >80 years compared to the 67-79 year-old
group. The likelihood o f using an AVF at first dialysis was lower in the youngest and
oldest groups (<55 years and >80 years) compared to the 55-66 and 67-79 year-old
groups. The likelihood o f using an AVF at first dialysis was similar in 55-66 and 67-79
year-old groups. Likelihood was also comparable between the <55 years and >80 years
age groups. After adjusting for multiple patient characteristics, including demographics,
lifestyle behavior, employment and insurance status, physical/ functional conditions, and
comorbid conditions listed in Table 1, the likelihood of using an AVF at first dialysis
remained lower for the youngest and oldest groups (<55 years and >80 years) in
comparison to the 55-66 and 67-79 year-old groups (Table 3). Sensitivity analyses
revealed similar patterns between age and receipt of pre-ESRD nephrology care (N=
491,992) as well as age and receipt of pre-ESRD dietician care (N= 450,626) (data not
presented).

Discussion
This is the first study to our knowledge that examined age-related differences in
the use of an arteriovenous fistula at the initial hemodialysis treatment. Two specific
groups were identified as having the lowest rate of AVF use at their first hemodialysis
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treatment, those <55 years of age and those > 80 years of age. Our findings are consistent
with those o f Lilly et al. who reported lower odds of AVF placement among 195,756
adult incident hemodialysis patients older than 85 years of age (but not younger patients)
as well as for women, blacks, Hispanics, and persons with diabetes, peripheral vascular
disease, congestive heart failure, other cardiac disease, and underweight (Lilly et al.,
2012). In contrast to our analysis, they examined patients with 6 months or more of prior
nephrology care which may have pre-selected younger patients with insurance and may
explain why they only found the lower AVF rates among older patients.
A similar analysis by Patibandla et al. found increasing age, female sex, black
race, lower body mass index, urban location, certain comorbidities, and shorter pre-endstage renal disease nephrology care were associated with a significantly lower likelihood
of AVF being placed, even if it was not ready for use at the first dialysis treatment,
among 118,767 incident hemodialysis patients >67 years of age (Patibandla et al., 2013).
This study differed slightly from ours in that Patibandla et al. specifically looked at AVF
being placed prior to dialysis, in contrast to AVF being used at first dialysis as examined
in our analysis.
Study limitations include the cross sectional nature of the data that only allows us
to assess relationships and not causal effects. In addition, a prior report o f disagreement
between information from the CMS Medical Evidence Report and Medicare physician
claims for pre-ESRD care suggests the validity of CMS Medical Evidence Report is not
clear (Kim, Desai, Chertow, & Winkelmayer, 2012). We examined pre-ESRD nephology
and dietician care and found results similar to use of an AVF at initial dialysis,
recognizing that timing of pre-ESRD care is inherently less definitive than use of an AVF
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at dialysis. Finally, not all patients may be good candidates for an AVF (Gomes, Schmidt,
& Wish, 2013), but that should not prevent the renal community from striving to meet
Healthy People 2020 goals for pre-ESRD care (USRDS, 2013).
The recommendations from our study include the need for promoting more
universal insurance coverage such as expanded Medicaid and similar coverage for
uninsured as should be provided with the new Affordable Care Act (Health Resources
and Services Administration, 2011). In addition, prospective studies are needed to
examine specific interventions at provider and patient/family levels that may increase
access to timely quality care for patients with advanced CKD.

Implications for Nephrology Nurses
These findings should be a reminder to nephrology nurses, as members of the preESRD and ESRD patient care team and, in some cases, primary care providers, to not
only maintain diligence in facilitating quality pre-ESRD care but to be cognizant of the
additional risks that exist for younger (<55 years) and older (>80 years) patients related to
obtaining an AVF for use at the first dialysis treatment. Working closely with social
workers and family to address key socio-demographic issues may be important for
engaging and motivating many patients. Strategies to enhance care coordination between
primary care providers and the CKD/ESRD team should be explored by the all members
of the health care team, including nurses and nurse practitioners. There is growing
recognition and acceptance across multidisciplinary programs that nurse practitioners can
make a positive contribution to healthy outcomes through an expanded role in working
with public health agencies, community-based organizations (CBOs), and in-patient
units. Polkinghome et al. reported an increase in AVF placement from less than 50% to
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65% following the introduction of a multifaceted intervention that included a vascular
access nurse coordinator and an algorithm to prioritize surgery (Polkinghome,
Seneviratne, & Kerr, 2009). The present findings of both low rates of AVF use at the first
dialysis treatment and disparities of AVF use across age groups should prompt a call to
action by ANNA for nurses to more aggressively pursue a substantive leadership role on
the CKD/ESRD team. Initiatives may include the use o f nurse practitioners and/or
clinical nurse specialists in CKD clinics as suggested by Davis and Zuber (2013). A joint
initiative between ANNA and the American Society of Nephrology and/or Renal
Physicians Association may help to address the issue o f ensuring the highest quality of
care for patients with advanced CKD.
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Table 1. Patient Characteristics by Age Group
Age group
Patient characteristic

< 55 years
(n= 153,611)

55-66 years
(n=154,126)

67-79 years
(n=168,044)

> 80 years
(n=83,275)

Age (years), Mean ±SD

43.4±8.9

60.7±3.4

72.9±3.7

84.1±3.4

59.2

56.0

54.5

54.2

Non-Hispanic white

37.3

50.0

61.9

72.8

Non-Hispanic black

40.0

30.5

22.6

15.7

Hispanic

16.9

14.1

10.6

7.1

Other

5.8

5.4

4.9

4.3

66.3

79.4

91.3

93.7

No insurance

18.3

8.4

1.0

0.6

Medicaid only

23.7

14.5

2.4

1.4

Medicare only

5.9

12.9

22.1

21.4

Other/combination

52.0

64.2

74.5

76.7

9.8

7.8

4.4

1.6

Inability to ambulate (%)

3.4

6.6

8.7

11.1

Inability to transfer (%)

1.5

3.0

4.5

6.0

Needs assistance with daily
activities (%)

6.1

10.2

14.1

19.0

Institutionalized - Nursing
Home (%)

2.6

5.6

9.1

13.7

Hypertension (%)

83.7

85.2

85.0

84.5

Diabetes (%)

46.9

63.7

56.8

39.9

Congestive heart failure (%)

19.2

32.4

39.7

45.7

Arteriosclerotic heart disease

8.5

20.6

28.6

31.9

Male sex (%)
Race/ethnicity (%)

Employed at 6 months before endstage renal disease (%)
Insurance coverage (%)

Current smoker (%)
Physical/ functional conditions

Comorbid conditions

(%)
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Other heart diseases (%)

8.4

15.5

21.3

25.3

Cerebrovascular accident/
transient ischemic attack (%)

5.3

10.1

12.1

12.0

Peripheral vascular disease (%)

7.4

14.4

17.9

17.2

Amputation (%)

3.3

4.2

2.8

1.4

Chronic obstruction pulmonary
disease (%)

3.7

9.2

12.9

12.4

Cancer (%)

2.7

6.6

10.6

12.1

AVF at first dialysis (%)

12.4

14.6

14.7

12.3

Receipt of nephrologist care at
least 12 months before ESRD

22.7

27.1

29.6

28.0

10.3

11.8

11.6

10.6

Outcome8

(%)
Receipt of dietitian care at any
time before ESRD (%)

*Sample size varied: N= 526,145 for AVF, N= 491,992 for nephrologist care, and N= 450,626
for dietitian care.
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Table 2. Unadjusted Odds Ratios of Having an Arteriovenous Fistula at First
Hemodialysis

Age Group

Odds ratio

95% Cl

P value

55-66 vs. <55 years

1.21

(1.18-1.23)

0.000

67-79 vs. <55 years

1.22

(1.19-1.24)

0.000

>80 vs. <55 years

0.99

(0.96-1.01)

0.313

67-79 vs. 55-66 years

1.01

(0.99-1.03)

0.354

>80 vs. 55-66 years

0.82

(0.80-0.84)

0.000

>80 vs. 67-79 years

0.81

(0.79-0.83)

0.000
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Table 3. Adjusted Odds Ratios of Having an Arteriovenous Fistula at First
Hemodialysis

Age G roup

Odds ratio8 95% C l

P value

55-66 vs. <55 years

1.18

(1.15-1.21)

0.000

67-79 vs. <55 years

1.16

(1.14-1.19)

0.000

>80 vs. <55 years

0.98

(0.95-1.01)

0.173

67-79 vs. 55-66 years

0.99

(0.97-1.01)

0.208

>80 vs. 55-66 years

0.83

(0.81-0.85)

0.000

>80 vs. 67-79 years

0.84

(0.82-0.86)

0.000

8Adjusted for the patient characteristics listed in T able!.
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Abstract
Background and objectives: Receipt of pre-end-stage renal disease (ESRD) clinical care
can improve outcomes for maintenance hemodialysis (MHD) patients. The study
addressed age-related variations in receipt of a composite o f recommended care to
include nephrologist and dietician care and use of arterio-venous fistula at first outpatient
hemodialysis.
Findings: Less than 2% o f MHD patients received all three forms of pre-ESRD care, and
63.3% received none o f the three elements of care. The mean number of pre-ESRD care
elements received by the oldest group (>80 years) did not differ from the youngest group
(< 55 years), but was less than the 55-66 and 67-79 years groups; adjusted ratios of 0.93
(0.92-0.94; p <0.001) and 0.94 (0.92-0.95; p < 0.001), respectively.
Conclusions: A major effort is needed to ensure comprehensive pre-ESRD care for all
patients with advanced CKD, especially for the youngest and oldest patient groups, who
were less likely to receive recommended pre-ESRD care.
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Introduction
Chronic kidney disease (CKD) is a major public health problem affecting one in
eight adults (Levey, Andreoli, DuBose, Provenzano, & Collins, 2007) and leading to endstage renal disease (ESRD) requiring treatment with renal transplantation or dialysis
(Stevens & Levin, 2013) or premature mortality (Go, Chertow, Fan, McCulloch, & Hsu,
2004). The psychosocial and economic burden of ESRD has challenged the nephrology
community to promote early detection and intervention to improve outcomes for patients
with CKD ( Rettig, Vargas, Norris, & Nissenson, 2010; Rettig, Norris, & Nissenson,
2008).
For patients with advanced CKD, early referral for specialty care may slow the
decline in renal function (Chen et al., 2008; Jones, Roderick, Harris, & Rogerson, 2006)
and reduce subsequent mortality (Jones, Roderick, Harris, & Rogerson, 2006). It is also
associated with reduced progression to ESRD and improved quality of life and clinical
outcomes after the initiation of dialysis (Brick & Ellis, 2009; Lee et al., 2014; Smart,
Dieberg, Ladhani, & Titus, 2014). In addition to improving patient outcomes, timely preESRD care can reduce health care costs for those needing replacement renal therapy
(Ismail, Neyra, & Hakim, 1998; Stroupe et al., 2011). Because of these reports, clinical
practice guidelines now recommend that all patients in advanced stages (stage 4 and 5) of
CKD receive nephrology care (Levey, Atkins, et al., 2007; Stevens & Levin, 2013).
Unfortunately, as many as 30-50% of patients undergoing maintenance dialysis in the
United States do not receive adequate pre-ESRD care before starting dialysis (United
States Renal Data System [USRDS] 2013).
The issue of quality care for patients with advanced CKD is an important concern

for the nephrology nursing community (American Nephrology Nurses' Association
[ANNA], 2013; Harford, Clark, Norris & Yan, in press) and the American Nephrology
Nurses' Association has taken the position that all patients requiring maintenance
hemodialysis therapy should have quality pre-ESRD care prior to initiating hemodialysis
(ANNA, 2013). The nursing paradigm o f four interrelated concepts of person, health,
environment, and nursing described by McEwen and Wills (2007) provides an ideal
conceptual framework for pre- ESRD education. This is particularly important since
nurses are frequently key members of the pre-ESRD education team, and holistic, patientcentered care and education may assist the individual with advanced CKD to receive the
necessary pre-ESRD care and achieve optimal health (Key, 2008).
Two key factors contributing to the increasing prevalence of CKD are an aging
population and the increasing prevalence of diabetes and hypertension, the leading CKD
risk factors (Erdem, Prada, & HafFer, 2013). While ESRD affects persons of all ages, it is
more common with advancing age, with one of every two patients starting hemodialysis
over 65 years of age. People in this age group comprise the fastest growing segment of
the kidney failure population (Drawz, Babineau, & Rahman, 2012; USRDS, 2013), and
those over 80 years of age are at even higher risk for ESRD (USRDS 2013).
Diabetes now accounts for an estimated 45% of new cases of kidney failure and
hypertension for an additional 30% (USRDS, 2013). These conditions are even more
common among ESRD patients with increasing age (Yan et al., 2013). Age has been
associated with differences in the presence of a functioning arteriovenous fistula (AVF)
at initial dialysis treatment, suggesting age may affect receipt of pre-ESRD care (Harford,
Clark, Norris, & Yan, in press). For example, an analysis of the Department of Veterans

Affairs (VA) and Medicare healthcare systems found that one-third of older veterans
initiating dialysis did not receive pre-ESRD nephrology care (Fischer et al., 2010). The
implications of aging and ESRD for the national healthcare system are substantial and
understanding the quality o f pre-ESRD and ESRD care for the elderly are Centers for
Medicare and Medicaid Services (CMS) priorities.
To better determine if age influences the quality of pre-ESRD care, we conducted
a national population analysis to assess potential age-related differences in the composite
of three pre-ESRD care elements that are part of the CMS clinical performance metrics:
(a) receipt of nephrology care at least 12 months prior to the initiation of dialysis, (b)
dietitian care prior to the initiation of dialysis, and (c) the use o f AVF for the first dialysis
treatment in maintenance hemodialysis patients (MHD). We hypothesized that older
patients were less likely to have received the composite of CMS recommended pre-ESRD
care elements than their younger counterparts.

Methods
Data Sources and Study Population
The study included all new MHD patients treated with renal replacement therapy
living in any of the 50 states or the District of Columbia who were 18 years of age or
older at the time of initiation of dialysis and entered in the United States Renal Data
System (USRDS) between 2005 and 2010. USRDS is a national population-based
registry that includes almost all U.S. patients with kidney failure. In 2005, the CMS
ESRD Medical Evidence (ME) Report was revised to include information on pre-ESRD
care that patients had received during the year prior to initiation of renal replacement
therapy. Data collection included all patients who completed the revised ME form.
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Study Variables
Data extracted from the USRDS included the three elements of recommended
pre-ESRD care: (a) receipt of care by a nephrologist at least 12 months prior to starting
dialysis, (b) receipt of care by a dietitian at any time prior to starting dialysis, and (c)
whether a patient used an AVF at the first outpatient dialysis session. Data extracted also
included gender, race and ethnicity, age at dialysis onset, lifestyle behavior (current
smoking), health care access, health insurance status at the initiation o f dialysis,
physical/functional conditions, and various comorbid conditions (e.g., diabetes,
hypertension, cardiovascular diseases, and cancer). Employment status at six months
prior to ESRD was used as a proxy measure of access to health care. Each patient’s
health insurance status was assigned to one of four categories: no insurance, Medicaid
only, Medicare only, and other, including employer-group only and/or two or more
carriers. The study was approved by the Institutional Review Board (IRB) at University
of Virginia and the IRB at the University of San Diego.

Statistical analysis
The outcome was the composite o f the three pre-ESRD care elements for MHD
patients, measured as the total number of care elements received per patient (range: 0-3).
We used Poisson regression, which is appropriate for frequency data, to compare four age
categories (< 55 years, 55-66 years, 67-79 years, >80 years of age), expressed as ratios of
the mean number of care elements received by respective age groups compared to that in
the reference group. The ratios were adjusted for patient characteristics, including
demographics, lifestyle behavior, employment status and insurance, physical/functional
conditions, and various comorbid conditions listed in Table 1. The purpose of adjusted
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analysis was to assess whether any age-related differences in the composite of three preESRD care elements received persisted after accounting for the patient factors
considered. To compare these four age groups, we present results of pairwise
comparisons by the order of age group: age groups of 55-66 years, 67-79 years, and > 80
years compared with the youngest age group (<55 years). Then age groups of 67-79 years
and > 80 years were compared with the second youngest age group (55-66 years), and
finally the age group of > 80 years compared with the third youngest group (67-79 years).

Results
As indicated in Table 1,15.1% of the 412,291 patients were over 80 years of age, with
the rest relatively evenly distributed among the three other age groups. Compared to older
patients, those <55 years of age were more likely to be male, of a racial/ethnic minority
group, and uninsured, less likely to be employed at 6 months before ESRD, and less
likely to have most comorbid medical conditions. In contrast, those >80 years were more
likely to be non-Hispanic white, have insurance, have been employed, and have
functional disabilities than other age groups.
Table 2 presents findings related to receipt of pre-ESRD care elements for the
total sample as well as for specific age groups. Nearly two-thirds of patients (63.3%) did
not receive any o f the three care elements considered, 25% received one care element,
and roughly 10% received two care elements. Less than 2% received all three elements of
recommended pre-ESRD care. Overall, the average number of care elements received by
patients in the entire cohort was 0.50. Among patients less than 55 years of age, the mean
was 0.43, increasing to 0.52 for those in 55-66 year age group and 0.55 for those 67-79
years of age and then declining to 0.51 for the oldest group.

38

Regression Analyses
Both unadjusted and adjusted Poisson regression analyses were performed comparing the
mean number o f pre-ESRD care elements received (nephrologist care, dietitian care,
AVF used at initial dialysis) between the age groups (Table 3). In unadjusted analyses,
the older cohorts, including those over 80 years of age were significantly more likely to
have received the recommended composite care than the youngest age group (<55 years).
However, those over 80 years received less care than either the 55- to 66-year-olds (ratio
- 0.97 [0.96-0.99]) or the 67- to 79-year-olds (ratio - 0.92 [0.91-0.93]).
After adjusting for multiple demographic, clinical, and pre-ESRD health-care
access factors, there were no longer significant differences in the number of
recommended care elements received by the oldest (>80 years) and youngest (<55 years)
groups. However the oldest (>80 years) group still received significantly less care than
the 55- to 66-year-old group (ratio - 0.93 [0.92-0.94]) and the 67- to 79-year-old group
(ratio - 0.94 [0.92-0.95]) (See Table 3).

Discussion
This is the first study to our knowledge that examined at the national level agerelated differences in the receipt o f the composite of pre-ESRD nephrology and dietitian
care as well as the use of AVF at the first dialysis treatment. After multiple statistical
adjustments for patient level factors, receipt of the recommended elements of pre-ESRD
care was lower in the youngest and oldest groups (<55 years and >80 years) in
comparison to 55-66 and 67-79 year old groups. In addition we noted that pre-ESRD care
was extremely low with less than 2% of the MHD population reported to have received
all three forms of recommended care.
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Our findings o f lower receipt of composite pre-ESRD care are consistent with
those of Lilly et al. (2012), who reported lower odds of AVF placement among 195,756
adult incident MHD patients over 85 years of age. The current study builds upon our
prior report o f lower odds of AVF placement among MHD patients >80 years of age by
expanding to assess the composite of pre-ESRD care elements (Harford et al., in press).
Our findings were surprising as we hypothesized that the older patients would receive
lower levels o f composite pre-ESRD care. We expected younger patients to have lower
unadjusted rates o f pre-ESRD care due to less insurance coverage (USRDS, 2013), but
after adjusting for this and other patient-level factors, we anticipated they would no
longer have lower levels o f pre-ESRD care. Our primary hypothesis was that the oldest
patients would receive lower levels of composite pre-ESRD care based on prior evidence
of lesser delivery o f health care for the aging population after adjusting for insurance
coverage. Interestingly, we found it was both the oldest and youngest groups that
received lower levels o f composite pre-ESRD care after adjusting for patient factors.
It is known that nephrologist care prior to ESRD results in improved clinical
outcomes. Under a nephrologist’s care, patients are more likely to receive care from a
renal care team and receive other important pre-ESRD care services, including dietitian
referral, timely placement of AVF, and enhanced management of multiple co-morbid
conditions (Fayer, Nascimento, & Abdulkader, 2011; Prakash et al., 2010). In this study,
we examined how the rates of receiving these important care indicators varied among
different age groups of ESRD patients.
The elderly constitute a substantial and growing portion o f the ESRD population,
and rates of treated ESRD among the older elderly (>80 years) have risen by more than
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50% in the last decade (Tamura, 2009) Quality of life results are mixed with older ESRD
patients reporting similar levels of mental well being but reduced physical well-being in
comparison to their younger ESRD peers (Tamura, 2009). One o f the first dilemmas
encountered in the management of elderly patients approaching ESRD is deciding
whether to initiate renal replacement therapy (Vachharajani et al., 2014). Once a decision
has been made to initiate renal replacement therapy these patients should receive the
same quality of care as their younger ESRD peers. This can be challenging at times given
the high prevalence o f comorbidities and complex quality of life issues associated with
the older ESRD population. These factors pose substantial challenges for clinicians, such
as technical difficulties in the placement of an arteriovenous fistula, that complicate
clinical decision-making and provision of optimal care, (Vachharajani et al., 2014). By
examining the composite o f pre-ESD care elements, we are better able to examine the
broader risk for suboptimal care for the elderly. This approach provides an expansive
view not limited to technical vascular issues associated with aging.
Our findings o f an extremely low rate of composite pre-ESRD care likely reflects
a combination o f factors from fragmented care for patients with advanced CKD (Rastogi,
Linden, & Nissenson, 2008), to limited or no insurance for many with advanced CKD
(Owen & Norris, 1994), and not having a nephrologist and the nephrology team as the
primary care provider for patients with advanced CKD as they prepare to transition to
ESRD (Owen & Norris, 1994; Rastogi, Linden, & Nissenson, 2008). Regardless of the
reason(s), our findings highlight a major gap in pre-ESRD care delivery and underscore
the need for new models o f care to bridge this gap, such as nurse directed care and/or
health navigators.
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Study limitations include the cross sectional nature of the study design that only
allows us to assess associations and not causal effects. Not all patients may be good
candidates for an AVF, especially older elderly (Gomes, Schmidt, & Wish, 2013), but
that is why we also examined other aspects of pre-ESRD care. Finally, there has been a
report of disagreement between information from the CMS Medical Evidence Report and
Medicare physician claims for pre-ESRD care, suggesting the validity of data derived
from one or both may be questionable (Kim, Desai, Chertow, & Winkelmayer, 2012).
However, the CMS Medical Evidence Report is the most comprehensive source of preESRD care data available at the present time.

Implications for Nephrology Nurses
Clinical (e.g. poor vasculature for AVF placement) and/or psychosocial (fear,
trust, health beliefs) factors may underlie the less frequent receipt of composite preESRD care in younger and old elderly MHD patients. Given that nurses are frequently
providers of pre-ESRD education, a nurse-led quality improvement initiative grounded in
person, health, environment, and nursing might help to better engage these two groups of
high-risk patients, as well as the entire community of pre-ESRD patients (Key, 2008;
McEwen & Wills, 2007). The nursing approach o f assisting the individual with preESRD to attain balance through holistic, patient-centered care and education may help to
ensure that composite pre-ESRD goals are met (Key, 2008).
Quality improvement initiatives in geriatric ESRD care have been successfully
implemented and may ultimately improve care for elderly patients with ESRD (Tamura,
2009; Winkelmayer & Tamura, 2012). Our findings of reduced pre-ESRD care should
help to clarify some o f the opportunities for pre-dialysis decision-making and
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management in the older elderly as well as younger MHD patients. Given our results, it is
imperative that a more consistent approach to the provision o f pre-ESRD care needs to be
taken for this entire population.
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Table 1. Patient Characteristics by Age Group

< 55 years
(o=l 12,541)
Age (years), Mean ±SD
Male (%)
Race (%)
Non-Hispanic white
Non-Hispanic black
Hispanic
Other
Insurance (%)
No insurance
Medicaid only
Medicare only
Other/combination
Employed (%)
Hypertension (%)
Diabetes (%)
Congestive Heart Failure (%)
Arteriosclerotic Heart Disease
(%)
Other Cardiac Disease (%)
Cerebrovascular
accident/transient ischemic attack
(%)
Peripheral Vascular Disease (%)
Amputations (%)
Chronic Obstructive Pulmonary
Disease (%)
Current smoker (%)
Cancer (%)
Inability to ambulate (%)
Inability to transfer (%)
Needs assistance with daily
activities (%)
Institutionalized - Nursing Home
(%)

55-66 years 67-79 years
(n=113,096) (0=124,337)

> 80 years
(n=62,317)

43.4±8.9
59.8

60.7±3.4
56.1

72.9±3.7
54.6

84.1±3.4
54.2

36.8
40.8
16.8
5.6

50.0
30.9
14.0
5.1

62.5
22.5
10.4
4.6

73.7
15.4
6.9
4.0

19.2
24.1
6.0
50.7
66.7
83.7
47.2
20.4
9.2

8.7
14.5
13.1
63.7
80.3
85.5
64.0
34.1
22.1

1.0
2.2
22.0
74.8
92.3
85.6
57.1
41.3
30.8

0.5
1.2
20.9
77.4
94.6
85.1
39.9
47.1
34.3

8.7
5.5

15.7
10.4

21.4
12.5

25.5
12.6

8.0
3.5
3.9

15.3
4.4
9.8

19.0
2.9
13.4

18.1
1.4
12.7

10.5
2.9
3.7
1.5
6.5

8.3
7.1
6.8
3.1
10.7

4.6
11.2
8.9
4.5
14.5

1.7
12.7
11.1
5.9
19.3

2.6

5.5

8.8

13.2
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Table 2. Receipt of Pre-ESRD Care Elements, by Age Group

< 55 years
(n=l 12,541)
Receipt of
nephrologist care
at least 12
months before
ESRD (%)
Receipt of
dietitian care at
any time before
ESRD (%)
AVF at first
dialysis (%)
Mean number of
the three care
elements
received
Percentage of the
three care
elements
received (%)
None
1 element
2 elements
All 3
elements

55-66 years 67-79 years > 80 years
(n=l 13,096) (n=124,337) (n=62,317)

Total
(N =
412291)

20.2

25.2

28.2

26.9

25.0

9.8

11.6

11.5

10.6

10.9

12.7

15.2

15.5

13.0

14.3

0.43

0.52

0.55

0.51

0.50

68.4
21.9
8.3
1.4

62.4
25.3
10.3
2.0

59.8
27.2
11.0
2.0

62.4
26.1
9.9
1.6

63.3
25.0
9.9

49

1.8

50

Table 3. Unadjusted and Adjusted Ratios of the Mean Number o f pre-ESRD Care
Elements Received for Respective Age Groups Compared with that In Reference Group

Age
Group

Ratio

P value

Ratio

P value

Ratio

P value

1 (reference)
.21 ( 1.20

1 (reference)

< 0.001

1.23)
67-79

1.29(1.27
1.30)

< 0.001

1.06(1.05
1.07)

1.18(1.16
1.20 )

< 0.001

0.97 (0.96
0.99)

< 0.001

1 (reference)
< 0.001

1 (reference)
1.09(1.07

< 0.001

1 (reference)

1. 10)

67-79

1.08(1.07

< 0.001

1. 10)

1.01 (0.99
1.03)

1 (reference)

0.99 (0.98
1.00 )

<0.180

0.93 (0.92
0.94)
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< 0.001

< 0.001
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Abstract
Background and Objectives: Coordination of benefits (COB) between the Centers for
Medicare & Medicaid Services (CMS) national healthcare system and other healthcare
insurance systems plays an important role in the determination o f cost covered services
for the end stage renal disease (ESRD) patient.

Methods: The study reviewed the 30-month ESRD Coordination Period policy in the
Territory of Puerto Rico over an 8-month period. The review included a search of
regulatory documents and key stakeholder interviews with healthcare professionals,
patients, and regulatory agencies in the Territory of Puerto Rico and the Centers for
Medicaid & Medicare Services regional office.

Findings: In the Territory o f Puerto Rico, the ERSD coordination policy is three months
based on a local 90-day ESRD coordination period policy versus the national regulatory
guidelines of 30 months. The variance interpretation o f the ESRD COB has led to
confusion among the payors, healthcare providers, the Medicare Administrative
Contractor, and the patient in determining primary and secondary payor status for
Medicare. This confusion has led, in turn, to delayed payments for health care delivery
systems and duplication o f copayments and out-of-pocket cost burden for patients.

Conclusions: A major effort is needed to harmonize the coordination period policy
between the Territory o f Puerto Rico and the national healthcare system to reduce undue
burdens on providers and patients.
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Introduction
Chronic kidney disease (CKD) is a major source of premature morbidity affecting
more than 10% o f adults in the United States. Over 110,000 people each year develop
end-stage renal disease (ESRD) requiring renal replacement therapy with either dialysis
or renal transplantation (Centers for Disease Control and Prevention [CDC], 2014;
National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2014). In
1972, to address the growing disease burden, a special provision of the Social Security
Act declared persons with ESRD who required renal replacement therapy to be disabled
for purposes of Medicare Parts A and B. Medicare was established just seven years
earlier in 1965 to support health care for the elderly and subsequently extended to
disabled persons by Social Security Act amendments (Rettig, 2011). The ESRD Medicare
program has now been in place for over 40 years.
At the level o f the individual patient, the ESRD Medicare Secondary Payer
provision or ESRD Coordination Period provides for a coordination of benefits period
between Medicare and private health insurance plans for individuals entitled to Medicare
solely on the basis of ESRD. If an individual is entitled to Medicare because of ESRD
and is covered by an Employer Group Health Plan (EGHP), the EGHP is the first payer
(primary) for the first 30 months (Centers for Medicare and Medicaid Services [CMS],
2013a). When first enacted in 1981, the period of coverage was 18 months, but was
extended to 30 months in 1997 by the Balanced Budget Act (CMS, 2002). The regulation
stipulates the EGHP is primary regardless o f the number of employees and/or the
Medicare beneficiary's employment status. This stipulation applies to all 50 states; the
District of Columbia; the Commonwealth of Puerto Rico; the Virgin Islands; Guam; the
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Commonwealth of the Northern Mariana Islands; and American Samoa as well as the
territorial waters adjoining the land areas of the United States for services provided
onboard a ship (CMS, 2013b). The 30-month ESRD Coordination Period has been
implemented in every region o f the United States except of the territory of Puerto Rico
(C. Hernandez, personal communication, May, 2014; First Coast Service Options Inc.
2014a). We undertook the present study to better understand the implications of
differences in the interpretation and implementation o f the Coordination Period policy in
Puerto Rico.
Methods
We conducted a search o f regulatory documents as well as key stakeholder
interviews regarding the 30-month ESRD Coordination Period in the territory of Puerto
Rico generated over an 8-month period. A synthesis of findings and implications for the
way forward are presented here.

Findings
Many dialysis patients in Puerto Rico have other (EGHP) insurance, but the
insurance covers only the first 90 days of dialysis treatments after the onset of ESRD. For
such patients, Medicare is the primary payer for dialysis treatments during the standard
ESRD beneficiary coordination period, which extends from the fourth through the 30th
month after onset of ESRD rather than after the 30th month. In Puerto Rico, Medicare
Secondary Payer (MSP) billing does not apply in such situations, as the health care
insurers in Puerto Rico do not interpret the Medicare Coordination period to begin after
30 months. Typically, in other areas where the 30* month rule is enforced, Medicare
becomes the primary payer after the 30th month coordination period. In Puerto Rico,
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however, Medicare is the secondary payer after the third month. The interpretation of
Medicare’s status as primary payer is believed to be supported by the Medicare
regulations at 42 CFR §411.161 and §411.162 and by the guidelines at CMS 100-05
(MSP Manual) Chapter 1 §10.2 and §70.3 and Chapter 3 § 10.2 (CMS, 2009,2012a,
2012b; National Archives and Records Administration, 2014)). These interpretations
have set forth the 90-day coordination period practiced in Puerto Rico to differ from the
30-month coordination period practiced elsewhere. This has important implications for
dialysis care facilities, nephrologists, and the patients they care for.
The CMS claims system has no procedure to allow for Medicare as the primary
payer for these beneficiaries who are within the 3rd -30th month ESRD period. Insurance
companies and healthcare providers use the Common Working File (CWF) to obtain
Medicare health insurance eligibility information. The CWF informs the claim system if
the beneficiary is within the coordination period and if the individual has other insurance
(e.g., EGHP). The aggregate insurance information and patient demographic data assist
both Medicare and the healthcare provider in determining whether Medicare is the
primary or secondary payer (CMS, 2013c, 2013d). The CWF does not include a data field
that would identify the dialysis treatment as not covered by an active insurer and allow a
Medicare primary payment. From our discussions, it is the position of intermediary
insurers in Puerto Rico that dialysis treatment could be categorized as not covered by the
insurer and that Medicare would then become the primary payer. They also voiced the
perception that CMS has chosen not to invest in a system improvement that would
directly address this situation.
First Coast Service Options Inc. (FCSO, 2014b), the Medicare Administrative
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Contractor (MAC) for Puerto Rico, uses a work-around in order to pay the claims for
these beneficiaries. The work-around instructs dialysis facilities to enter occurrence code
24 and the “date o f receipt of denial by higher priority payer” on the claim form. An
occurrence code 24 is intended for use when it is believed that another insurer covers a
service but the insurer denies payment (CMS-104, Chapter 8, § 50.3) (CMS, 2013e). It
allows the contractor to make a conditional payment, that is, a payment governed by MSP
billing procedures. Both FCSO and the Puerto Rico dialysis facilities understand that the
payments are actually primary, not conditional payments, as does CMS.
FCSO requires dialysis facilities and nephrologists to actually bill the
beneficiary’s other insurer as if it were an MSP billing situation and assumes the insurer
provides dialysis services as a cost-covered service as practiced on the U.S. mainland.
Dialysis facilities and nephrologists do not submit the insurer denial with the claim; they
are to retain it on file as documentation to confirm their entitlement to receive payment in
case the claims are audited. This, unfortunately, can lead to the patient encountering
additional out-of-pocket deductibles and additional bills related to the imposed insurer
denial in this process. These bills are associated with the payer denying payment to the
healthcare provider and then the healthcare provider may bill and pursue collection from
the patient.
Although not intended by FCSO to create an onerous condition for dialysis
facilities and nephrologists, the work-around procedure does so and, as noted above, also
imposes an additional burden on patients. It requires dialysis facilities and nephrologists
to expend resources to bill other insurers for services that they know the insurers do not
cover so they can fill in a date for condition code 24 and file the record o f denial. The

59

insurers have no incentive to cooperate with the work-around process and may not
respond to the claim or respond very late. At best, dialysis facility and nephrologists
billing for Medicare eligible services are substantially delayed. At worst, providers’
billing staff may lose track of some of the cases in the confusion resulting in a loss of
revenue. If the standard Medicare claims system was revised so that it could recognize
the claims at issue as payable by Medicare as primary payer, dialysis facilities and
nephrologists would be entitled to bill immediately upon service and would be entitled to
receive payment after the claims clear, as early as 14 days and no later than 29 days after
claim submission. Claims not processed within that time would be payable with interest.
Through no fault o f their own, dialysis facilities and nephrologists do not receive these
benefits.
In addition, some patients encounter partial coverage of care through two insurers
(EGHP and Medicare) adding unnecessary co-payments and confusion around which
insurer is the primary provider for other non-dialysis ESRD-related care. Confusion
regarding cost-covered ESRD and non-ESRD services among the insurance agencies,
patients, and the healthcare providers is a result of the common working file’s inability to
process the claims of the newly diagnosed ESRD Medicare beneficiaries residing in
Puerto Rico. This can lead to patients overpaying, or, even worse, unintended missed
payments to an insurer, which could be forwarded to a collection agency leading to a
poor credit rating or even legal proceedings. CMS educational materials for ESRD
patients cover insurance issues related to the 30-month coordination period, but there are
no materials or trainings for patients in Puerto Rico who must figure out on their own
insurance issues based on a 90-day coordination period and any differences in
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apportionment of ESRD-related services.

Recommendations
The ideal solution is for the territory of Puerto Rico to adopt the 30-month ESRD
coordination period. In lieu of that, one approach to a work-around at the provider level
would be to revise how claims are processed in the common working file in a way that
appropriately reduces the patient’s, dialysis facilities’, and nephrologists’ administrative
burdens as follows. The common working file should incorporate an exception or waiver
that allows the billing of ESRD beneficiaries who reside in Puerto Rico to be processed
after 90 days, rather than 30 months. That common working file is a system that is
usually simple for FCSO to manage, protects the Medicare trust fund against improper
payments, and meets CMS’s timely and accurate payment objectives. When the Medicare
beneficiary begins dialysis treatment, the provider would complete a questionnaire
designed to determine whether Medicare is the primary or secondary payer. Puerto Rico
beneficiaries typically have other insurance coverage, but not for dialysis
services. According to the MSP manual, Chapter 3, § 10.1.5E (CMS, 2012c), “If the
information obtained does not indicate EGHP coverage, the provider annotates the bill to
that effect (e.g., EGHP coverage lapsed, benefits exhausted)”. That statement suggests
that the Medicare claims system may actually have the flexibility to make primary
payments for these claims without a major work-around, but merely adding the exception
or waiver for Puerto Rico. If so, then the solution to dialysis facilities’ and nephrologists’
problem might already exist within standard billing procedures.
At a patient level, this would also help to address the additional insurance
coverage gap. Many patients with a Medicare Prescription Drug Plan reach a point where
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their medication coverage runs out, known as the "donut hole". The traditional "donut
hole" is due to a temporary limit on what a medication plan will cover. Patients in Puerto
Rico not only face this issue, but also frequently face having to pay two deductibles for
medications and other services due to having two insurers with unclear policies around
attribution of coverage for costs as ESRD versus non-ESRD services and which insurer is
responsible, creating a second “donut hole”.
In summary, if the adoption o f the 30-month ESRD coordination period is not
feasible and a work-around were still necessary, we recommend a process in which the
provider would not bill the EGHP, but would still enter a date with condition code 24 that
would be pre-approved by CMS to allow the claim to be processed. Alternatively, if a
date is not required in the notation field, a standard comment appropriate to the situation
could be entered. Thus, the claim could be submitted without delay and processed
without error.
Dialysis facilities and nephrologists would still have to obtain and keep adequate
documentation of the beneficiary’s lack of other insurance coverage for dialysis
treatments during the ESRD coordination period. The documentation might consist of
copies o f the insurance contracts that show the benefits covered and any limitations. New
copies of contracts could be obtained periodically to make sure there are no changes. If
there are any further doubts, the insurer might be billed and issue an initial denial which
could suffice throughout the remainder of the coordination period.
Effectively addressing the issue o f a unique interpretation of the 30-month ESRD
Coordination Period would be o f significant benefit to both providers and patients. The
proposed solutions represent potential strategies to more effectively address this issue.
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Again, a more complete solution would be to create a seamless and harmonized ESRD
reimbursement system for the United States and all of its territories.
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Chapter Five
Summary and Discussion
Two studies and a concept analysis were conducted addressing potential gaps in
patient care management for chronic kidney disease. The reports included: Relationship
between Age and Timely Placement o f Vascular Access in Incident Patients on
Hemodialysis, Relationship between Age and Pre-End Stage Renal Disease Care in
Elderly Hemodialysis Patients, and Regional Variations in the Interpretation o f the ESRD
30-Month Coordination Period. The studies were partitioned into two areas of chronic
kidney disease (CKD) research: the analysis of age-related differences in the receipt of a
composite o f recommended care to include nephrologist and dietician care and use of an
arteriovenous fistula at first outpatient dialysis. The concept analysis addressed regional
variations in the interpretation of the end stage renal disease (ESRD) 30-month
coordination period. This chapter will provide an overview of the findings, the
significance to research, nursing practice, and health policy, and a proposed plan for
future research based on the studies’ findings and nursing implications.
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Findings and Statistical Analysis of Manuscripts
The first study Relationship Between Age and Timely Placement o f Vascular
Access in Incident Patients on Hemodialysis addressed the potential age related
differences in use of a functioning arteriovenous fistula (AVF). The United States Renal
Data System (USRDS), a national population based registry maintaining the largest
dialysis data bank on almost all U.S. renal patients was used to extract dialysis data. The
database houses and monitors characteristic profiles of renal-related disease groups,
vulnerable populations, and communities with pre-end stage renal disease and kidney
failure. For this study, the key variable was whether a patient used an AVF at the first
outpatient hemodialysis therapy. Other study variables included demographic
characteristics, employment status, health insurance coverage, and co-morbid conditions.
Four age groups were examined: <55 years of age, 55 to 66 years of age, 67 to 79
years of age, and >80 years of age. Data were collected between the years 2005 through
2010. The study included all new maintenance hemodialysis (MHD) patients treated with
renal replacement therapy (RRT) in any of the 50 states or the District of Columbia who
were 18 years or older at the time o f initiation of dialysis and entered in the USRDS. U.S.
territories were excluded. A total of 559,056 individuals were reviewed: 153,611
(27.5%) were younger than 55 years of age, 154,126 (27.6%) were 55 to 66 years of age,
168,044 (30%) were 67 to 79 years of age and 83,275 (14.9 %) were 80 years of age and
older.
Logistic regression and descriptive analysis were used in the data analysis.
Multiple analyses were conducted in adjusting for both unadjusted odds ratios with
logistic regression, and then the odds ratios adjusted for other patient demographic data
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and characteristics. The study hypothesized that older patients were less likely to have a
functioning AVF at the first dialysis treatment, however our findings showed the
likelihood o f using an AVF at first hemodialysis were lower for the youngest group and
oldest groups (less than 55 years of age and 80 years and older).
In order to get a more comprehensive analysis o f age related differences in the
composite receipt o f pre-ESRD care; a second study was conducted. Unlike the first
study, this study increased the number of key study variables (pre-ESRD care elements)
and was designed on a broader scale. The second study was an expansion of the first.
Here we looked at a composite of three CMS recommended pre- ESRD care elements. In
addition to the placement o f a functioning AVF at the initial onset of incident
hemodialysis care, the authors reviewed receipt of nephrologist care at least 12 months
prior to receiving dialysis treatment and care by a dietician at any time prior to starting
dialysis, resulting in a total of three pre-ESRD composite elements of care. Parallel to the
first study, the USRDS database was used for data extraction. The same age groups were
also used for comparative review. A sample of 412,291 individuals was examined. The
study also hypothesized that older patients were less likely to receive the composite of
CMS recommended pre-ESRD care elements than their younger counterparts.
The study used Poisson regression to evaluate findings. Poisson regression was
used, which is most appropriate for frequency data, to compare four age categories (<55
years of age, 55 to 66 years o f age, 67 to 79 years of age, and > 80 years of age)
expressed as ratios o f the mean number of care elements received by respective age
groups compared to that in the reference group (the 55-66 year group). The outcome
variable was the composite o f the three pre-ESRD care elements for MHD patients,
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measured as the total number o f care elements received per patient (range: 0-3). Multiple
analyses were conducted to evaluate for both adjusted and unadjusted ratios using patient
characteristics and demographics, and other study variables. Consistent with the first
study, the key findings revealed the receipt of recommended elements of care was lowest
in the youngest (<55 years of age) and oldest groups (> 80 years o f age) when compared
to the two groups in between. In addition to the above findings, the analysis revealed
overall pre-ESRD care was extremely low. Less than 2% of the MHD population was
reported to have received all three elements o f recommended care. The actual receipt of
care was 1.4%.
The concept analysis examined regional variations in the interpretation of the
ESRD 30-month Coordination Period. Over an 8-month period, the authors conducted a
search of regulatory documents as well as key stakeholder interviews regarding
coordination of benefits for the ESRD patient. The findings revealed discordance in the
interpretation and implementation of ESRD cost covered services between the Territory
of Puerto Rico and the national ESRD insurance program. Many dialysis patients in
Puerto Rico have employee group healthcare plans (EGHP), which cover dialysis
services up to 90 days after the onset of ESRD (First Coast Services Options Inc.
[FCOS], 2014; Centers for Medicaid and Medicare Services [CMS], 2014). Based on the
ESRD coordination period in Puerto Rico, after the 90-day period Medicare becomes the
primary payer for dialysis treatments. This finding is contrary to the federal regulatory
guidelines and practice in other states and territories where the ESRD Coordination
Period is 30 months and not limited to 90 days after the onset of kidney failure (Code of
Federal Regulations, 2011; CMS, 2013). It is important to note the national framework
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for processing ESRD audit and reimbursement claims processing is structured to
coordinate ESRD claims processing on a 30-month coordination period, not 90 days.
The current system does not allow for a seamless payer transition for Medicare as
the primary payer for ESRD patients residing in Puerto Rico after the 90-day
coordination period. Consequently, this has created confusion among the payers,
healthcare providers, and the patients in determining who are the primary and secondary
payers. In addition, the extra work necessary to process the claims management and
handing has resulted in an increase billing cost.

Research Questions and Hypothesis Findings
The conducted studies answered four questions central to the receipt of preESRD composite care elements and policy variations on the 30-month Coordination
Period policy for ESRD patients in the Territory of Puerto Rico. The first three questions
examined the receipt o f pre-ESRD composite care elements and were answered by the
first two studies:
1. Is there a difference in rate of placement of an AVF prior to initiation of
hemodialysis between persons aged > 67 years of age and those < 67 years of
age?
2. Is there a difference in the rate of receipt o f early nephrology care prior to
initiation of hemodialysis between persons aged > 67 years of age and those < 67
years of age?
3. Is there a difference in the rate of receipt of dietary care prior to initiation of
hemodialysis between persons aged > 67 years of age and those < 67 years of
age?
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As discussed earlier, our combined study findings revealed a low rate on the receipt of
the three composite pre-ESRD care elements overall. These findings were consistent with
the first study on AVF placement prior to the initiation o f initial dialysis. In addition, the
study hypothesized that persons aged > 67 years received a lower level of quality of care
than younger persons < 67 years of age, however our findings indicated that both the
younger and older age groups experienced a lower quality on the receipt of pre-ESRD
care elements and not just the older age group as initially hypothesized.
The last question examined regional variances in the ESRD 30-month Coordination
Period policy and was addressed in the policy analysis:
1. Is there a difference in the interpretation and implementation of the Coordination
Period policy in Puerto Rico?
Our search on regional variance on the interpretation of the ESRD 30-month
Coordination Period policy identified Puerto Rico as practicing a different ESRD
coordination policy. While other territories and states work under a 30-month
coordination period, Puerto Rico operates under a 90-day system. As discussed earlier,
this variation in practice creates a complex processing system for ESRD claims resulting
in higher billing costs and greater out-of-pocket expenses for patients, as well as
confusion among the healthcare providers, payors and patients in determining order of
payors.
Discussion
To our knowledge, these studies are the first o f their kind examining age-related
differences in the use o f an AVF at the initial dialysis treatment along with the receipt of
nephrology and dietician care prior to the start o f dialysis care. Our findings are
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consistent with earlier research indicating older patients as having lowest rate of AVF
placement at initial treatment along with other pre-ESRD care elements (Lilly et al.,
2012, Kim; Dessai, Chertow, & Winkelmayer, 2012). Work conducted by Gomes,
Schmidt, & Wish (2013) discussed the clinical and pre-ESRD care challenges for those
patients who may not be good candidates for AVF placement in addition to overall low
rates o f early CKD care in general. A thematic finding on pre-ESRD care studies is early
nephrology care continues to be consistently low if not absent. Our findings were
consistent with these studies.
The promotion o f universal healthcare insurance coverage for pre-ESRD services
across all age groups is needed to slow down the national burden o f kidney disease. As
noted in the regional variances of the ESRD coordination policy in Puerto Rico,
confusion on cost covered services may lead to patients not seeking appropriate care for
fear of high out-of-pocket expense. In addition, this confusion may also lead to healthcare
providers not admitting new CKD patients for fear of non-payment. A re-examination of
the national claims processing system is warranted based on Puerto Rico’s ESRD
coordination policy. A more harmonized management of the overall billing and claims
system may assist in simplifying the claims processing for Puerto Rico, the Medicare
Administrative Contractor, and the national healthcare insurance program.

Implications
The summative findings of the three studies should be a reminder to all
nephrology nurses as members of the pre-ESRD and ESRD multidisciplinary care team;
nurses can make a difference at various levels of the healthcare spectrum. From policy
development, research, and clinical practice, nurses have the opportunity to be at the

73

forefront in the patient care and chronic disease management for the pre-ESRD and
ESRD patient.

Significance to Research
Based on the study’s findings, immediate action is needed to implement a more
comprehensive pre-ESRD patient care program and monitor its impact on the delivery of
all three pre-ESRD care elements. Monitoring patient outcomes after initiation of renal
replacement therapy may lead to improved early management of CKD and improved preESRD and ESRD healthcare economics. Two key factors contributing to the increasing
prevalence of CKD are an aging population and the leading CKD risk factors, diabetes
and hypertension (Erdem, Prada, & Haffer 2013). Nurse researchers are strategically
poised to assist in ESRD policy revision and innovative changes influencing the
preventive and long-term management of chronic disease particularly with the aged
ESRD patient. Collaborative partnerships with other professional healthcare agencies
supporting kidney disease care platforms provide greater funding opportunities for renal
research.
The first two studies described here specifically excluded data related to patients
in the U.S. territories and protectorates. Similar research on the extent o f pre-ESRD care
and age-related discrepancies are warranted for those populations.

Significance to Nursing Practice
Currently national certification for the advanced nephrology nurse practitioner
does not exist. The opportunity to develop a more expanded role for a nationally certified
Advanced Nephrology Nurse Practitioner may help in the long-term care of both the preESRD and ESRD patient. Gaps in the literature review support the need for new and

74

innovative initiatives expanding the role for the renal nurse generalist, advanced nurse
practitioner, and the renal patient care team (Davis & Zuber, 2013). The development of
an advanced nephrology renal practitioner role may help to fill this void.

Significance for Health Policy
Clinical and/or psychosocial factors may underscore the less frequent receipt of
pre-ESRD composite care in the older and younger kidney disease populations. Given
that nurses are frequently providers of pre-ESRD education, a nurse-led quality
improvement initiative grounded in person, health, environment, and nursing might help
to better engage these two groups of high-risk patients, as well as the entire community of
pre-ESRD patients (Key, 2008; McEwen & Wills, 2007). The nursing approach of
assisting the individual with pre-ESRD to attain balance through holistic, patient-centered
care and education may also assist to ensure that composite pre-ESRD goals are met
(Key, 2008).
Quality improvement initiatives in geriatric ESRD care have been successfully
implemented and may ultimately improve care for elderly patients with ESRD (Tamura,
2009; Winkelmayer & Tamura, 2012). Our findings of reduced pre-ESRD care should
help to clarify some o f the opportunities for pre-dialysis decision-making and
management in the older as well as younger MHD patients. Given our results, it is
imperative that a more consistent approach to the provision of pre-ESRD care needs to be
taken for this entire population.
At its most granular level, the nursing profession is patient-centric. This makes
nurses unique in their ability to work one on one with both patient and family. More
importantly, it positions them as strong patient advocates and clinicians. The confluence
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of these attributes places nurses at the leadership helm to assist in policy revision,
development, and implementation.

Proposed Plan
The research assisted in further identifying gaps in the care of the dialysis patient
population at a federal and territorial level, all of which influence renal disease
management, nursing practice, and ultimately ESRD healthcare policy. In order to clearly
understand next steps in the furtherance of the study, study limitations have been
addressed. Study limitations include the cross sectional nature of the data that only
allowed the team to assess relationships and not causal affects. In addition, prior reports
have suggested the validity o f the shared information from the CMS Medical Evidence
Report and Medicare physician claims for pre-ESRD care is not clear, indicating a need
for a more in-depth review of the data utilization and data management at a more
germane level (Kim et al., 2012). The team plans to further investigate the utilization of
other integrated healthcare and population census databases, which may help to improve
the validity of the current database and provide opportunities for expansion into other
research platforms. Adding a secondary database may strengthen future studies.
Finally, the research team has proposed that future studies are needed at the
territorial level to obtain a better understanding of possible patient care gaps and potential
economic effects at the federal and local level. Because the demand for dialysis care
continues to grow, there is an urgent need for more studies in the renal area relating to
policy and nursing practice. This study provided a platform for future territorial studies
and in other areas with similar populations (e.g., rural settings).
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